Drug recall · February 1, 2017
Amoxicillin for Oral Suspension USP recall
Why: Subpotency: due to a low, out of specification test result for assay during stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-4150-73
- Lots / codes
Lot # 35432507A, 35434914A, 35435798A, 35437490A, Exp 9/19
- Quantity
- 133,601 bottles
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- United States and Puerto Rico
- Initiated
- December 21, 2016 · Voluntary: Firm initiated
- Classified
- January 24, 2017
- Reported
- February 1, 2017
- Ended
- February 6, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amoxicillin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.